1-5 of 5
Qing Zeng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics

Joyce F. Liu, Sangeetha Palakurthi, Qing Zeng, Shan Zhou, Elena Ivanova, Wei Huang, Ioannis K. Zervantonakis, Laura M. Selfors, Yiping Shen, Colin C. Pritchard, Mei Zheng, Vilmos Adleff, Eniko Papp, Huiying Piao, Marian Novak, Susan Fotheringham, Gerburg M. Wulf, Jessie English, Paul T. Kirschmeier, Victor E. Velculescu, Cloud Paweletz, Gordon B. Mills, David M. Livingston, Joan S. Brugge, Ursula A. Matulonis, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1263–1273.
https://doi.org/10.1158/1078-0432.CCR-16-1237
Published: 28 February 2017
View articletitled, Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
Open the PDF for Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics in another window
Includes: Supplementary data
Journal Articles

C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin

Zhijian Gao, Xiaoyin Xu, Bruce McClane, Qing Zeng, Babak Litkouhi, William R. Welch, Ross S. Berkowitz, Samuel C. Mok, Elizabeth I.O. Garner
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1065–1074.
https://doi.org/10.1158/1078-0432.CCR-10-1644
Published: 01 March 2011
View articletitled, C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin
Open the PDF for C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin in another window
Includes: Supplementary data
Journal Articles

Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38

Sufi M. Thomas, Qing Zeng, Michael W. Epperly, William E. Gooding, Ira Pastan, Qing Cheng Wang, Joel Greenberger, Jennifer Rubin Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 7079–7087.
https://doi.org/10.1158/1078-0432.CCR-04-0587
Published: 22 October 2004
View articletitled, Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38
Open the PDF for Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38 in another window
Journal Articles

Enhanced Antiangiogenic Therapy of Squamous Cell Carcinoma by Combined Endostatin and Epidermal Growth Factor Receptor-Antisense Therapy

Mengfeng Li, Caisheng Ye, Chong Feng, Frank Riedel, Xiaoning Liu, Qing Zeng, Jennifer Rubin Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3570–3578.
Published: 01 November 2002
View articletitled, Enhanced Antiangiogenic Therapy of Squamous Cell Carcinoma by Combined Endostatin and Epidermal Growth Factor Receptor-Antisense Therapy
Open the PDF for Enhanced Antiangiogenic Therapy of Squamous Cell Carcinoma by Combined Endostatin and Epidermal Growth Factor Receptor-Antisense Therapy in another window
Journal Articles

Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole

Qing Zeng, David C. Smith, Todd J. Suscovich, William E. Gooding, Donald L. Trump, Jennifer Rubin Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2245–2251.
Published: 01 June 2000
View articletitled, Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole
Open the PDF for Determination of Intermediate Biomarker Expression Levels by Quantitative Reverse Transcription-Polymerase Chain Reaction in Oral Mucosa of Cancer Patients Treated with Liarozole in another window